PD 160170

PD 160170 is a compound developed to inhibit low-risk myelodysplastic syndrome-associated anemia with activities that promote red blood cell transfusion independence and increase hemoglobin.

Product Specifications

CAS Number

181468-88-2

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Neuropeptide Y Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/pd-160170.html

Smiles

O=S(C1=CC(N)=C(N=CC=C2)C2=C1[N+]([O-])=O)(C3=C(C=CC=C3)C(C)C)=O

Molecular Formula

C18H17N3O4S

Molecular Weight

371.41

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]8-Amino-5-nitro-6-phenoxyquinolines: potential non-peptidic neuropeptide Y receptor ligands

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

C5855 96 Tests

Cornifin-B (SPRR1B) Human ELISA Kit

View Details

AR50068PU-S 100 µg

UBE2D4 (1-147, His-tag) Human Protein

View Details

orb3031202-01 100 mg

4-[2- (2-Pyridyl) ethyl]morpholine

View Details

orb3031202-02 2 mg

4-[2- (2-Pyridyl) ethyl]morpholine

View Details

orb3031202-03 10 mg

4-[2- (2-Pyridyl) ethyl]morpholine

View Details

MBS2133958-01 0.1 mL

APC_Cy7 Linked Monoclonal Antibody to Hedgehog Homolog, Sonic (SHH)

View Details